Hematology Analyzers and Reagents Market

The global hematology analyzers and reagents market is projected to reach USD 10.33 billion by 2031 from USD 7.57 billion in 2025, at a CAGR of 6.4% from 2026. The hematology analyzers market is primarily driven by the rapid integration of artificial intelligence to enhance diagnostic accuracy and optimize laboratory workflows, as well as the increasing adoption of advanced parameters and multifunctional testing capabilities. In addition, the growing demand for cost-efficient testing solutions with high first pass yield, reduced reagent use, and improved laboratory efficiency is further supporting market growth.

However, the market faces several challenges, including the increasing complexity of managing and interpreting data generated by next-generation hematology analyzers, stringent regulatory requirements and quality control standards that increase the compliance burden, and ongoing laboratory workforce shortages that affect workflow efficiency and limit the optimal utilization of advanced systems.

To know about the assumptions considered for the study download the pdf brochure

As of 2025, the key players operating in the global hematology analyzers and reagents market are Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden Corporation (Japan), Siemens Healthineers (Germany), Abbott Laboratories (US), Boule Diagnostics AB (Sweden), Horiba, Ltd. (Japan), Bio-Rad Laboratories Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd.  (China), and F. Hoffmann-La Roche Ltd. (Switzerland).

Sysmex Corporation (Japan)

Sysmex is one of the leading technology and manufacturing product-based companies. The company is involved in developing and manufacturing analyzers and reagents for hematology and hemostasis solutions. The company offers instruments, reagents, and maintenance services. Sysmex operates in more than 40 countries across the world’s major markets, including North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. The firm's export business operates in more than 190 countries worldwide. Some of the company's subsidiaries include RIKEN GENESIS (Japan), Sysmex America, Sysmex Europe, Sysmex Asia Pacific, Sysmex Shanghai (China), Sysmex Polska, Sysmex (Malaysia) Sdn Bhd, and Sysmex (Thailand).

Danaher Corporation (US)

Danaher Corporation has a major presence in the worldwide market for hematology analyzers and reagents. The Danaher Corporation has developed an excellent range of hematology analyzer products through its diagnostics business unit, Beckman Coulter, which includes the DxH family of instruments, namely DxH 900 and DxH 900 Connected Workcell for high volume, DxH 690T for mid volume, and DxH 560, DxH 520, and DxH 500 for low volume. The hematology analyzer range is capable of producing accurate counts and differential results with high sensitivity and intelligent flagging with automated capabilities.

Abbott Laboratories (US)

Abbott is an innovative company involved in the development and launch of products in the field of hematology analyzers and reagents. Abbott creates a unique range of products to provide effective solutions for use by specialists in the industry to analyze blood. Abbott’s portfolio includes a wide variety of hematology analyzers and integrated laboratory systems that are capable of providing precise results on the first attempt without any manual work being needed, and maximizing the effectiveness of the work of laboratory staff. Abbott’s Alinity h-series, which falls into the category of the general Alinity line, is one of such innovations.

Related Reports:

Hematology Analyzers and Reagents Market by Product [Instrument (PoC, 5 part, 6 part), Reagents, slide stainers] & Service, Price (High, Mid, Low), Application (Infectious Diseases, Blood Cancer), End User (Hospital, CTL, Govt Lab) — Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]